Literature DB >> 22307269

GNAQ and GNA11 mutations in melanocytomas of the central nervous system.

Rajmohan Murali, Thomas Wiesner, Marc K Rosenblum, Boris C Bastian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22307269      PMCID： PMC3495609          DOI： 10.1007/s00401-012-0948-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  6 in total

1.  Mutations in GNA11 in uveal melanoma.

Authors:  Catherine D Van Raamsdonk; Klaus G Griewank; Michelle B Crosby; Maria C Garrido; Swapna Vemula; Thomas Wiesner; Anna C Obenauf; Werner Wackernagel; Gary Green; Nancy Bouvier; M Mert Sozen; Gail Baimukanova; Ritu Roy; Adriana Heguy; Igor Dolgalev; Raya Khanin; Klaus Busam; Michael R Speicher; Joan O'Brien; Boris C Bastian
Journal:  N Engl J Med       Date:  2010-11-17       Impact factor: 91.245

2.  Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin.

Authors:  Igor Adameyko; Francois Lallemend; Jorge B Aquino; Jorge A Pereira; Piotr Topilko; Thomas Müller; Nicolas Fritz; Anna Beljajeva; Makoto Mochii; Isabel Liste; Dmitry Usoskin; Ueli Suter; Carmen Birchmeier; Patrik Ernfors
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

3.  Independent regulation of hair and skin color by two G protein-coupled pathways.

Authors:  Catherine D Van Raamsdonk; Gregory S Barsh; Kazumasa Wakamatsu; Shosuke Ito
Journal:  Pigment Cell Melanoma Res       Date:  2009-07-21       Impact factor: 4.693

4.  Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis.

Authors:  I W McLean; W D Foster; L E Zimmerman
Journal:  Hum Pathol       Date:  1982-02       Impact factor: 3.466

5.  Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.

Authors:  Catherine D Van Raamsdonk; Vladimir Bezrookove; Gary Green; Jürgen Bauer; Lona Gaugler; Joan M O'Brien; Elizabeth M Simpson; Gregory S Barsh; Boris C Bastian
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

6.  Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.

Authors:  Heidi V N Küsters-Vandevelde; Annelies Klaasen; Benno Küsters; Patricia J T A Groenen; Ilse A C H van Engen-van Grunsven; Marcory R C F van Dijk; Guido Reifenberger; Pieter Wesseling; Willeke A M Blokx
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088
  6 in total
  20 in total

1.  Molecular alterations in malignant blue nevi and related blue lesions.

Authors:  Ismail Yilmaz; Mehmet Gamsizkan; Sule Ozturk Sari; Banu Yaman; Cuyan Demirkesen; Aylin Heper; Aylin Orgen Calli; Gizem Narli; Zafer Kucukodaci; Ufuk Berber; Dilaver Demirel; Taner Akalin; Murat Demiriz; Nesimi Buyukbabani
Journal:  Virchows Arch       Date:  2015-09-24       Impact factor: 4.064

2.  Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.

Authors:  Klaus J Busam; Heinz Kutzner; Lorenzo Cerroni; Thomas Wiesner
Journal:  Am J Surg Pathol       Date:  2014-07       Impact factor: 6.394

3.  Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms.

Authors:  Heidi V N Küsters-Vandevelde; Ilse A C H van Engen-van Grunsven; Sarah E Coupland; Sarah L Lake; Jos Rijntjes; Rolph Pfundt; Benno Küsters; Pieter Wesseling; Willeke A M Blokx; Patricia J T A Groenen
Journal:  Pathol Oncol Res       Date:  2014-10-15       Impact factor: 3.201

4.  Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic Tumors.

Authors:  Johannes A P van de Nes; Christian Koelsche; Marco Gessi; Inga Möller; Antje Sucker; Richard A Scolyer; Michael E Buckland; Torsten Pietsch; Rajmohan Murali; Dirk Schadendorf; Klaus G Griewank
Journal:  J Invest Dermatol       Date:  2017-05-10       Impact factor: 8.551

5.  Investigation of Somatic GNAQ, GNA11, BAP1 and SF3B1 Mutations in Ophthalmic Melanocytomas.

Authors:  Jasmine H Francis; Thomas Wiesner; Tatyana Milman; Helen H Won; Amy Lin; Vivian Lee; Daniel M Albert; Robert Folberg; Michael F Berger; Devron H Char; Brian Marr; David H Abramson
Journal:  Ocul Oncol Pathol       Date:  2016-01-27

Review 6.  The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

Authors:  Boris C Bastian
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

7.  Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.

Authors:  Johannes van de Nes; Marco Gessi; Antje Sucker; Inga Möller; Mathias Stiller; Susanne Horn; Simone L Scholz; Carina Pischler; Nadine Stadtler; Bastian Schilling; Lisa Zimmer; Uwe Hillen; Richard A Scolyer; Michael E Buckland; Libero Lauriola; Torsten Pietsch; Andreas Waha; Dirk Schadendorf; Rajmohan Murali; Klaus G Griewank
Journal:  J Neurooncol       Date:  2016-01-07       Impact factor: 4.130

8.  Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation Signature.

Authors:  Johannes van de Nes; Karsten Wrede; Adrian Ringelstein; Mathias Stiller; Susanne Horn; Antje Sucker; Inga Möller; Simone L Scholz; Rajmohan Murali; Marco Gessi; Dirk Schadendorf; Klaus G Griewank
Journal:  J Invest Dermatol       Date:  2016-04-07       Impact factor: 8.551

Review 9.  Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.

Authors:  Thomas Wiesner; Heinz Kutzner; Lorenzo Cerroni; Martin C Mihm; Klaus J Busam; Rajmohan Murali
Journal:  Pathology       Date:  2016-01-18       Impact factor: 5.306

Review 10.  Primary sellar melanocytoma: pathological, clinical and treatment review.

Authors:  L Albano; M Losa; L R Barzaghi; G Spatola; P Panni; M R Terreni; P Mortini
Journal:  J Endocrinol Invest       Date:  2019-12-03       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.